Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.
Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
Halio is developing adaptive, dynamic glass for the commercial, residential, and automotive markets.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Fellow Health provides peer-reviewed, clinical semen analysis solutions that patients can conveniently perform at home.
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
Magnetic Insight is a biotechnology company that offers cellular imaging to measure the efficacy of cancer immunotherapies.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Bioz is a disruptive startup at the intersection of information technology and scientific research.
Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.
Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.
Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.
Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.
Nvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.
5AM Ventures has invested in 68 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
5AM Ventures's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 27 different industry categories.
Among tracked funding rounds, MapLight Therapeutics received $372.5M in a Series D round. 5AM Ventures's total known invested capital is $5.6B.
5AM Ventures's average investment size is $107.3M across its portfolio of 68 companies.
Recent 5AM Ventures portfolio additions include ProLynx, Precede Biosciences, Lifordi Immunotherapeutics, Halio, Kinaset Therapeutics. These companies were founded in 2020 or later.